Intravenous fluid therapy for hospitalized and critically ill children: rationale, available drugs and possible side

Thomas Langer1, Rosamaria Limuti, Concezione Tommasino

  • 1Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy. thomas.langer@unimi.it.

Insights

Children are prone to fluid and electrolyte imbalances, making parenteral fluid therapy critical. This review covers fluid balance, risks, and current practices for intravenous fluids in pediatric patients.

Area of Science:

  • Pediatrics
  • Nephrology
  • Critical Care Medicine

Background:

  • Children have a higher percentage of body water than adults, increasing susceptibility to fluid and electrolyte imbalances.
  • Parenteral fluid therapy is essential for hospitalized children, particularly newborns and infants.
  • Intravenous fluids are potent drugs with specific indications, contraindications, and potential side effects.

Purpose of the Study:

  • To review the physiology and pathophysiology of water and electrolyte balance in children.
  • To highlight the prevalence of non-osmotic antidiuretic hormone release in critically ill children.
  • To discuss available crystalloids, their properties, and side effects in pediatric patients.

Main Methods:

  • Review of water and electrolyte balance physiology and pathophysiology.
  • Analysis of non-osmotic antidiuretic hormone release in pediatric populations.
  • Evaluation of crystalloid characteristics and side effects for pediatric use.
  • Examination of current clinical practices for parenteral fluid therapy in children.

Main Results:

  • Children are at significant risk for water and electrolyte disturbances.
  • Non-osmotic antidiuretic hormone release is common in hospitalized and critically ill children.
  • Crystalloids vary in tonicity, necessitating careful selection for pediatric patients.

Conclusions:

  • Understanding fluid and electrolyte balance is crucial for safe and effective parenteral fluid therapy in children.
  • Distinguishing between hypotonic and isotonic fluids is vital for preventing adverse events.
  • Current practices involve consensus on resuscitation/replacement fluids but ongoing debate on maintenance fluids.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
344
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
289
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
338
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
370
Routes of Drug Administration: Parenteral01:25

Routes of Drug Administration: Parenteral

The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
3.1K
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
522